zaditor children

The Interactive Talk presentation, "Artificial Intelligence and non-/micro-invasive was cost-effective in a Randomized Trial", tramadol yellow capsule will be presented by Falk Schwendicke, Charite – Universitaetsmedizin Berlin, Germany and take place on Saturday, June 25th, 2022 at 2 p.m. China Standard Time (UTC+08:00) during the "e-Oral Health Network I" session.

The study investigated the cost-effectiveness of AI-supported detection of proximal caries in a randomized controlled clustered cross-over superiority trial. Twenty-three dentists assessed 20 bitewings; 10 of which were randomly evaluated supported by an AI-based software and the other 10 without AI. The study then evaluated the proportion of true and false positive and negative detections and the treatment decisions taken for each detected lesion (non-invasive, micro-invasive, invasive). The results found that for detecting early (E2 or D1) lesions, dentists were significantly more sensitive when using AI. However, treatment decisions determined the lifetime cost-effectiveness.

If, however, all detected early lesions had been treated non- or micro-invasively, AI was far less costly (266; (200-352) Euro) than no AI. AI applications should not only support caries detection, but also subsequent evidence-based management of caries lesions.

Source:

International & American Associations for Dental Research

Posted in: Device / Technology News | Medical Research News

Tags: Artificial Intelligence, Craniofacial, micro, Research

Comments (0)

Source: Read Full Article